Alfentanil is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Akorn. The primary component is Alfentanil Hydrochloride.
| Product ID | 17478-841_01d255dd-327d-4f3e-bce1-6591b233b796 |
| NDC | 17478-841 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Alfentanil |
| Generic Name | Alfentanil Hydrochloride |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-07-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019353 |
| Labeler Name | Akorn |
| Substance Name | ALFENTANIL HYDROCHLORIDE |
| Active Ingredient Strength | 500 ug/mL |
| Pharm Classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2013-07-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019353 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-07-19 |
| Marketing Category | NDA |
| Application Number | NDA019353 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-07-19 |
| Marketing Category | NDA |
| Application Number | NDA019353 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-07-19 |
| Marketing Category | NDA |
| Application Number | NDA019353 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-07-19 |
| Ingredient | Strength |
|---|---|
| ALFENTANIL HYDROCHLORIDE | 500 ug/mL |
| SPL SET ID: | c965d63f-933b-4a83-88f6-c8c74159530b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 17478-841 | Alfentanil | Alfentanil Hydrochloride |
| 0409-2266 | Alfentanil Hydrochloride | Alfentanil Hydrochloride |
| 17478-067 | Alfentanil Hydrochloride | Alfentanil Hydrochloride |